Visit our Christmas Gift Finder
Peptides in Oncology III: Somatostatin and LH-RH Analogues - Recent Results in Cancer Research 153 (Paperback)
  • Peptides in Oncology III: Somatostatin and LH-RH Analogues - Recent Results in Cancer Research 153 (Paperback)
zoom

Peptides in Oncology III: Somatostatin and LH-RH Analogues - Recent Results in Cancer Research 153 (Paperback)

(editor), (editor)
£114.00
Paperback 98 Pages / Published: 18/09/2011
  • We can order this

Usually dispatched within 3 weeks

  • This item has been added to your basket
Interference with protein-mediated intra- and intercellular pathways has become a major goal of preclinical and clinical research. A ,rapidly increasing numBer of peptides are known to be responsible for endo-, para-and autocrine sig- nal transduction. These peptides and their receptors have been studied with regard to their cell growth stimulatory ac- tion and their impact on differentiation. In parallel, peptide antagonists are being investigated in terms of their potential role in preclinical and clinical application. Thus, biotherapy might improve the clinical outcome of patients with tumors that respond to the respective hormonal manipulation. Among the numerous peptides of interest somatostatin (somatotropin release inhibitory factor) and the luteinizing hormone releasing hormone (LH-RH) have been the topic of intensive research during recent years. In this third vol- ume of peptides in oncology, experts in the field exten- sively review and update the mechanisms of action of so- matostatin and LH -RH -analogues in oncology. Somatostatin and its various short-and long-acting ana- logues have the unique feature of suppressing and inhibit- ing a wide range of cellular processes including cell prolif- eration. Receptors for these peptides which belong to the family of neuropeptides or neurotransmitters, are widely distributed, a feature which is not in keeping with the gen- eral view of a growth hormone regulatory system. LH -RH analogues play an established role in curative (adjuvant) and palliative treatment of hormone sensitive tumors.

Publisher: Springer-Verlag Berlin and Heidelberg GmbH & Co. KG
ISBN: 9783642640384
Number of pages: 98
Weight: 185 g
Dimensions: 235 x 155 x 5 mm
Edition: Softcover reprint of the original 1st ed. 200

You may also be interested in...

Cancer Care
Added to basket
£7.99
Paperback
Cancer: A Very Short Introduction
Added to basket
Radical Remission
Added to basket
B is for Breast Cancer
Added to basket
The Cancer-Fighting Diet
Added to basket
The Emperor of All Maladies
Added to basket
Medicine Hands
Added to basket
£29.99
Paperback
The Cancer Survivor's Companion
Added to basket
Beat Cancer
Added to basket
£14.99
Paperback
Oxford Handbook of Oncology
Added to basket
£34.99
Part-work (fascículo)
Physics for Clinical Oncology
Added to basket
The Biology of Cancer
Added to basket

Reviews

Please sign in to write a review

Your review has been submitted successfully.